Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
Gpqc35Ew9A3vyqDg
